Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites by Furong Kou, Jifang Gong, Yan Li, Jian Li, Xiaotian Zhang, Jie Li, Lin Shen

Get full text

Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K‐Akt signaling in gastric cancer by Cheng Zhang, Mengqi Zhang, Sai Ge, Wenwen Huang, Xiaoting Lin, Jing Gao, Jifang Gong, Lin Shen

Get full text

Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study by Furong Kou, Furong Kou, Jian Li, Yanshuo Cao, Zhi Peng, Ting Xu, Lin Shen, Jifang Gong, Xicheng Wang

Get full text

CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer by Changsong Qi, Tong Xie, Jun Zhou, Xicheng Wang, Jifang Gong, Xiaotian Zhang, Jian Li, Jiajia Yuan, Chang Liu, Lin Shen

Get full text

810 Preliminary safety, tolerability and efficacy results of KN026 in combination with KN046 in patients with HER2 aberrated solid tumors by Dan Liu, Jing Yang, Lin Shen, Yue Yang, Ting Xu, Jifang Gong, Zhi Dong, June Xu, Yakun Qi, Jie Men, Paul Kong

Clinicopathological Characteristics and Response to Chemotherapy in Treatment-Naive Epstein–Barr Virus Associated Gastric Cancer: A Retrospective Study by Tong Xie, Zhi Peng, Yiqiang Liu, Zhening Zhang, Xiaotian Zhang, Jian Li, Ming Lu, Jifang Gong, Changsong Qi, Jiafu Ji, Lin Shen

Get full text

Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance? by Zhihao Lu, Li Yang, Jingwei Yu, Ming Lu, Xiaotian Zhang, Jian Li, Jun Zhou, Xicheng Wang, Jifang Gong, Jing Gao, Jie Li, Yan Li, Lin Shen

Get full text

Autophagy inhibition enhances PD-L1 expression in gastric cancer by Xiaojuan Wang, William K. K. Wu, Jing Gao, Zhongwu Li, Bin Dong, Xiaoting Lin, Yilin Li, Yanyan Li, Jifang Gong, Changsong Qi, Zhi Peng, Jun Yu, Lin Shen

Get full text

Pyrotinib combined with CDK4/6 inhibitor in HER2‐positive metastatic gastric cancer: A promising strategy from AVATAR mouse to patients by Zuhua Chen, Yingying Xu, Jifang Gong, Furong Kou, Mengqi Zhang, Tiantian Tian, Xiaotian Zhang, Cheng Zhang, Jian Li, Zhongwu Li, Yumei Lai, Jianjun Zou, Xiaoyu Zhu, Jing Gao, Lin Shen

Get full text

Correction: Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer by Keren Jia, Yang Chen, Yu Sun, Yajie Hu, Lei Jiao, Jie Ma, Jiajia Yuan, Changsong Qi, Yanyan Li, Jifang Gong, Jing Gao, Xiaotian Zhang, Jian Li, Cheng Zhang, Lin Shen

Get full text

Hyperprogression of cutaneous T cell lymphoma after anti–PD-1 treatment by Yumei Gao, Simeng Hu, Ruoyan Li, Shanzhao Jin, Fengjie Liu, Xiangjun Liu, Yingyi Li, Yicen Yan, Weiping Liu, Jifang Gong, Shuxia Yang, Ping Tu, Lin Shen, Fan Bai, Yang Wang

Get full text

Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer by Keren Jia, Yang Chen, Yu Sun, Yajie Hu, Lei Jiao, Jie Ma, Jiajia Yuan, Changsong Qi, Yanyan Li, Jifang Gong, Jing Gao, Xiaotian Zhang, Jian Li, Cheng Zhang, Lin Shen

Get full text

Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment by Yang Chen, Keren Jia, Yu Sun, Cheng Zhang, Yilin Li, Li Zhang, Zifan Chen, Jiangdong Zhang, Yajie Hu, Jiajia Yuan, Xingwang Zhao, Yanyan Li, Jifang Gong, Bin Dong, Xiaotian Zhang, Jian Li, Lin Shen

Get full text

Pyrotinib alone or in combination with docetaxel in refractory HER2‐positive gastric cancer: A dose‐escalation phase I study by Dan Liu, Furong Kou, Jifang Gong, Zhiqiang Wang, Xiaotian Zhang, Jian Li, Yan Li, Jie Li, Jun Zhou, Ming Lu, Xicheng Wang, Zhihao Lu, Yanshuo Cao, Jianjun Zou, Xiaoyu Zhu, Ruihua Xu, Lin Shen

Get full text

Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer by Hui Chen, Lin Shen, Qi Zhang, Jian Li, Xiaochen Zhao, Jifang Gong, Zhenghang Wang, Xicheng Wang, Zhongwu Li, Yuezong Bai, Shiqing Chen, Changsong Qi, Feilong Zhao, Mifen Chen, Zhi Peng, Xiaotian Zhang, Jinping Cai

Get full text

Anticancer drug R&D landscape in China by Shen Zhao, Hongyun Zhao, Cheng Lv, Jifang Gong, Jian Zhang, Wenfeng Fang, Jin Li, Xichun Hu, Yi Ba, Binghe Xu, Yanqiao Zhang, Yun Fan, Kunyan Li, Xiaoyuan Chen, Zhimin Yang, Lin Shen, Li Zhang

Get full text

Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and... by Yakun Wang, Jifang Gong, Airong Wang, Jia Wei, Zhi Peng, Xicheng Wang, Jun Zhou, Changsong Qi, Dan Liu, Jian Li, Ming Lu, Zhihao Lu, Yanshuo Cao, Jiajia Yuan, Ruyan Zhang, Jianmin Fang, Xiaotian Zhang, Lin Shen

Get full text

A Phase Ib Study of the Simmitecan Single Agent and in Combination With 5-Fluorouracil/Leucovorin or Thalidomide in Patients With Advanced Solid Tumor by Qi Zhang, Ting Deng, Fen Yang, Weijian Guo, Dan Liu, Jiajia Yuan, Changsong Qi, Yanshuo Cao, Qiuqiong Yu, Huiming Cai, Zhi Peng, Xicheng Wang, Jun Zhou, Ming Lu, Jifang Gong, Jian Li, Yi Ba, Lin Shen

Get full text

A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer by Xi Jiao, Xin Wei, Shuang Li, Chang Liu, Huan Chen, Jifang Gong, Jian Li, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yujiao Wang, Yanni Wang, Na Zhuo, Henghui Zhang, Zhihao Lu, Lin Shen

Get full text

Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer by Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen, Zhihao Lu

Get full text